Burton, D W <br/><br/>
Monitoring of skeletal progression of prostate cancer by GFP imaging, X-ray, and serum OPG and PTHrP.  [electronic resource] 

 -  The Prostate  Feb 2005 
 - 275-81 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0270-4137 
<br/><br/><label>Standard No.: </label>10.1002/pros.20146  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--blood<br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Biomarkers, Tumor--blood<br/>Bone Neoplasms--blood<br/>Calcium--blood<br/>Carrier Proteins--blood<br/>Cell Line, Tumor<br/>Diphosphonates--pharmacology<br/>Disease Models, Animal<br/>Glycoproteins--blood<br/>Green Fluorescent Proteins--biosynthesis<br/>Humans<br/>Interleukin-6--blood<br/>Interleukin-8--blood<br/>Male<br/>Membrane Glycoproteins--blood<br/>Mice<br/>Mice, SCID<br/>Microscopy, Fluorescence<br/>Osteoprotegerin<br/>Pamidronate<br/>Parathyroid Hormone-Related Protein--blood<br/>Prostatic Neoplasms--blood<br/>RANK Ligand<br/>Radiography<br/>Receptor Activator of Nuclear Factor-kappa B<br/>Receptors, Cytoplasmic and Nuclear--blood<br/>Receptors, Tumor Necrosis Factor<br/>Transduction, Genetic